Lombard Odier Asset Management (Switzerland) SA - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 160 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
Lombard Odier Asset Management (Switzerland) SA ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$2,789,000
-19.9%
258,214
-15.4%
0.24%
-19.7%
Q2 2022$3,480,000
-23.8%
305,253
-39.1%
0.30%
-17.6%
Q1 2022$4,566,000
-69.3%
501,219
-49.7%
0.36%
-62.3%
Q4 2021$14,862,000
-36.8%
996,116
+8.9%
0.95%
-35.0%
Q3 2021$23,500,000
+16.5%
914,416
+18.2%
1.46%
+42.6%
Q2 2021$20,174,000
+6.5%
773,562
+44.1%
1.02%
-18.6%
Q1 2021$18,947,000536,7381.26%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
VV Manager LLC 1,798,163$76,997,00067.53%
Wildcat Capital Management, LLC 1,515,524$64,895,00022.42%
TPG Group Holdings (SBS) Advisors, Inc. 19,716,306$844,252,00014.91%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 1,279,281$54,779,0007.69%
Coastal Bridge Advisors, LLC 463,117$19,831,0006.33%
DSAM Partners (London) Ltd 235,098$10,067,0002.63%
Casdin Capital, LLC 625,000$26,763,0001.58%
Alpine Global Management, LLC 150,000$6,423,0001.13%
Perceptive Advisors 1,543,790$66,105,0001.07%
Avoro Capital Advisors LLC 1,128,594$48,326,0000.96%
View complete list of ALLOGENE THERAPEUTICS INC shareholders